Citadel Advisors
UTRS

Citadel Advisors’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Citadel Advisors’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-927
Closed -$15K – 15710
2022
Q3 		$15K Buy
+927
New +$35.1K ﹤0.01% 12168

Other funds holding UTRS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
LWM
Lyell Wealth Management Menlo Park, California $1.36B AUM 28.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's UTRS Position: Q4 2022 in Review

Citadel Advisors sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2022, closing a stake of 927 shares — an estimated $15K sold.

Citadel Advisors first reported a position in UTRS in Q3 2022 and held it in 1 quarter. The position peaked at $15K in Q3 2022. 20 funds tracked by Wall St. Rank hold UTRS as of Q4 2022.

  • Citadel Advisors reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 927 Minerva Surgical, Inc. Common Stock shares in Q4 2022, an estimated $15K.
  • Citadel Advisors first reported a position in Minerva Surgical, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Citadel Advisors's Minerva Surgical, Inc. Common Stock position peaked at $15K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.